Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Cortechs.ai Announces Major FDA 510(k)-Pending Update to NeuroQuant Software, Expanding Capabilities in Neuroimaging | ||
By: PR Newswire Association LLC. - 24 Apr 2024 | Back to overview list |
|
SAN DIEGO, April 24, 2024 /PRNewswire/ -- Cortechs.ai, a pioneer in AI-driven healthcare solutions, proudly announces a major update for its flagship product, NeuroQuant® v5.0, which is currently FDA 510(k) pending. This cutting-edge advancement marks a milestone in the field of neuroimaging AI, empowering healthcare professionals with unparalleled precision in diagnosing and monitoring neurological disorders. This latest update to NeuroQuant® will expand the use of the software to support identification and evaluation of cerebral microhemorrhages on susceptibility-sensitive MRI sequences - small focal brain lesions commonly found in patients with Traumatic Brain Injuries (TBI), Cerebral Amyloid Deposition Diseases including Cerebral Amyloid Angiopathy (CAA) and Alzheimer's Disease (AD), as well as patients with Amyloid Related Imaging Abnormalities (ARIA). "Our upcoming NeuroQuant® v5.0 application empowers healthcare professionals with precise data to inform diagnoses and monitor brain health. This innovation underscores our commitment to advancing neurological care for radiologists, neurologists, researchers, and patients alike." says Brandon Steach, Head of Product at Cortechs.ai. Nate White, Ph.D and Chief Technology Officer, says "Since the first commercial launch of NeuroQuant® in 2006, Cortechs continues to lead our industry, driving transformation through pioneering initiatives and fueling innovation in imaging-based AI technologies. The release of NeuroQuant® v5.0 strengthens our commitment to staying ahead of the curve and continuously pushing boundaries to provide AI-driven solutions to optimize patient care." About Cortechs.ai View original content to download multimedia:https://www.prnewswire.com/news-releases/cortechsai-announces-major-fda-510k-pending-update-to-neuroquant-software-expanding-capabilities-in-neuroimaging-302125591.html SOURCE Cortechs.ai |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |